A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Healthy Volunteer

Interventions

DRUG

ABBV-722

Oral Capsule

DRUG

Placebo

Oral Capsule

Trial Locations (1)

RECRUITING

Acpru /Id# 270279, Grayslake